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Abstract
Objective—This study aimed to compare the responsiveness to change of the Patient-Reported 
Outcomes Measurement Information System (PROMIS®) asthma impact and generic scales to a 
legacy scale, the Paediatric Asthma Quality of Life Questionnaire (PAQLQ).
Methods—229 child-parent dyads in public insurance programs were enrolled. PROMIS 
Pediatric Short Forms and the PAQLQ were used to measure health-related quality of life 
(HRQoL) across 4 time points (T1 to T4) over 2 years; the Asthma Control and Communication 
Instrument was used to measure change of asthma control; Global Rating of Change (GRC) for 
breathing problems and overall health were used to measure change of health status. 
Responsiveness was tested by comparing the changes of HRQoL with change of asthma control 
and health status over time using t-tests, generalized estimating equation, and relative validity 
approaches.
Results—The PROMIS asthma impact scale (p<0.05) and all PAQLQ scales (p’s<0.05) exhibited 
significant responsiveness when anchored to asthma control and health status. Several PROMIS 
generic scales (pain, fatigue, and mobility) also indicated adequate responsiveness.
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Conclusion—The PROMIS asthma impact scale indicated similar responsiveness to the PAQLQ. 
Due to its brevity and responsiveness, the PROMIS asthma impact scale is useful for clinical 
practice or research.
Keywords
Asthma; Children; Health-Related Quality of Life; Patient-Reported Outcomes Measurement 
Information System (PROMIS®); Responsiveness
Introduction
According to the 2012 National Health Interview Survey, approximately 6.8 million 
American children under 18 years of age had asthma [1]. Poorly controlled or uncontrolled 
asthma can lead to psycho-social-health impairments including sleep disturbances [2], 
school absenteeism [3], academic underperformance [4, 5], physical activity limitations [6], 
and poor health-related quality of life (HRQoL) [7–9].
Although several generic and asthma-specific HRQoL scales for children with asthma are 
available, most scales were developed using classical test theory (CTT) [10] that likely yield 
significant ceiling effects in HRQoL scores [11] and limit a scale’s ability to capture the full 
spectrum of the HRQoL related to asthma [12]. As a result, HRQoL scales derived from 
CTT may not sensitively identify important changes in HRQoL that mirror an underlying 
change in health status (e.g., asthma control status). Alternatively, item response theory 
(IRT) methodology allows for selecting items that are calibrated on the same metric and 
cover different levels of HRQoL on the latent continuum for asthma.
The concept of responsiveness to change refers to a scale’s ability to detect changes in 
HRQoL over time with the same directionality between the change of HRQoL and 
underlying health status [13, 14]. Small but meaningful changes are important to detect, 
particularly to estimate minimally important differences (MIDs) for use by clinicians [15]. 
Developed using IRT methodology, modern HRQoL scales, such as the Patient-Reported 
Outcomes Measurement Information System (PROMIS®) [16], may possess a superior 
responsiveness to change compared with the legacy scales that are derived from CTT.
Assessing responsiveness relies on the use of meaningful anchors and an appropriate time 
window to observe the HRQoL change [17]. However, previous responsiveness studies for 
pediatric asthma scales are not ideal because most investigations are based on data collected 
from only two time points that did not fully capture random variation related to 
measurements [18, 19]. One legacy scale, the Paediatric Asthma Quality of Life 
Questionnaire (PAQLQ), has shown significant responsiveness within and between study 
participants; however, this study used a small sample (N=52) in a single 9-week period [20].
Although psychometric properties of the PROMIS pediatric asthma impact and generic 
scales have been reported [10, 21–24], the longitudinal validity such as responsiveness has 
not been evaluated in a sample of asthmatic children. The main purpose of this study was to 
investigate the responsiveness of the PROMIS pediatric asthma impact and generic scales in 
asthmatic children and to compare responsiveness with the PAQLQ [20]. Data were 
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collected from dyads of asthmatic children and their parents within a 26-week observational 
window over a 2-year period. We hypothesized that for children whose asthma status has 
changed (either worse or better), the change in mean HRQoL scores will be statistically 
significant and in the expected direction.
Methods
Source of Data
This responsiveness study is based on the PROMIS Pediatric Asthma Study which was 
funded by the US National Institutes of Health and implemented by University of Florida 
(2009–2014) and St. Jude Children’s Research Hospital (2014–2015) to investigate the 
natural progression of health outcomes in asthmatic children.
Study Population
Study participants were child-parent dyads (N=229) recruited from the Florida Medicaid and 
State Children’s Health Insurance Program (SCHIP) between 2010 and 2011. Inclusion 
criterion for study participants were children who were between the ages of 8 and 17.9 
years, had been diagnosed with asthma (ICD-9-CM: 493.1, 493.2, or 493.x), had two or 
more asthma-related medical visits in the previous 12 months, and had a parent who was 
≥18 years old. Both children and parents who had been enrolled continuously in the Florida 
Medicaid or SCHIP in the past six months, were able to read and speak in English, and had 
internet access at home for the past six months were eligible for study participation. 
Potential participants were approached via mailed letter with a follow-up phone call to 
introduce the study. Informed consent was obtained from all individual participants included 
in the study. The study was approved by the University of Florida Institutional Review 
Board prior to data collection.
Study Design
Figure 1 shows the study design. Data collection periods comprised 13 weeks of observation 
in the first year (Weeks 1–13) and another 13 weeks in the second year (Weeks 14–26). Two 
cohorts with roughly equal numbers of participants were recruited during asthma-dependent 
seasons where asthma flares are prevalent. Data collection for the first cohort took place in 
the fall (September – December) and for the second cohort in the spring (January – April) in 
each respective year. At baseline of the first year (T1) and the second year (T3), 
sociodemographic, asthma control, peak flow values, and nighttime sleep quality/quantity 
data were collected from parents through the secured research website. Parents were asked 
to report continuously on their children’s asthma control status, peak flow values, and 
nighttime sleep quality/quantity every week until Week 13 in the first year and Week 26 in 
the second year. In each year, if asthma control status changed (worse or better) from the 
baseline week to a specific follow-up week, then HRQoL data from the child were collected 
through a telephone interview. If asthma control status did not change throughout the 13 
weeks, HRQoL data from the child were only collected at Week 13 and Week 26, 
respectively. To keep participants engaged and minimize the attrition rate, asthma 
educational materials on seven topics were delivered via mail and a study website during the 
8-month gap between T2 and T3.
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Primary Measures
Anchors—Two types of anchors were used to test responsiveness: a clinical anchor to 
assess changes in asthma control status, and retrospective judgment anchors to assess 
changes in breathing problems and overall health status.
Clinical Anchor: Asthma Control Status—Asthma control status was collected using 
the Asthma Control and Communication Instrument (ACCI) [25, 26] which is a 12-item 
questionnaire completed by the parent. The ACCI includes 5 items that assess asthma 
control; 3 items for asthma-related acute health care; 1 item for asthma symptoms; 1 item for 
medication adherence; 1 item for how much asthma bothers the participant; and 1 qualitative 
item that asks about patient and doctor communication. The most severe response from the 
5-items that measure asthma control is used to classify a child into four severity categories 
(mild-intermittent, mild-persistent, moderate-persistent, and severe-persistent) based on the 
National Heart, Lung and Blood Institute’s guidelines [27]. The ACCI was administered 
each week and changes in control status were classified as ‘better’ (from poor to good 
control), the ‘same’ (no change), and ‘worse’ (from good to poor control). The ACCI has 
demonstrated good psychometric properties [26] and can discriminate poor versus good 
asthma control status in a diverse sample of children [25].
Retrospective Judgment Anchor: Global Rating of Change—The Global Rating 
of Change (GRC) Index was used to assess a participant’s self-perception of the 
improvement or deterioration in breathing problems and overall health status over time. 
Administered at T2 and T4, children were asked to report if their breathing problems and 
overall health were better, worse, or about the same since the last time they did the survey. 
The change status was classified as better, the same, or worse.
HRQoL—HRQoL was measured using the PROMIS Pediatric Short Forms and the 
PAQLQ.
PROMIS Pediatric Short Forms—PROMIS Pediatric Short Forms [28] were developed 
using qualitative (i.e., focus group and cognitive debriefing) and quantitative (i.e., IRT) 
methodology. In this study, six domains were administered, including asthma impact (8 
items), fatigue (10 items), pain interference (8 items), depressive symptoms (8 items), 
physical functioning – mobility (8 items), and peer relationships (8 items). Each PROMIS 
item used the context statement “In the past 7 days.” Responses included 5-point Likert-type 
categories ranging from “never” to “almost always” in the majority of domains and from 
“with no trouble” to “not able to do” in the physical functioning domain. Domain scores 
were calculated based on the scores of corresponding items and then converted to a T-score 
metric with a mean of 50 and a standard deviation of 10 derived from the original calibration 
sample of children [29]. Higher scores indicate better outcomes in the domains of physical 
functioning – mobility and peer relationships, and worse outcomes in the domains of asthma 
impact, fatigue, pain interference, and depressive symptoms. PROMIS pediatric asthma 
impact and generic scales have shown good measurement properties including test-retest 
reliability, construct validity, convergent-discriminant validity, and known-group validity 
[10, 21–24].
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Paediatric Asthma Quality of Life Questionnaire (PAQLQ)—The PAQLQ is the 
most widely used scale to measure asthma-specific HRQoL for children [20]. It is a self-
report scale that consists of 23 items capturing three domains: symptoms (10 items), activity 
limitation (5 items), and emotional function (8 items). The PAQLQ has demonstrated 
acceptable reliability and responsiveness to change [19, 20]. Each child was asked to report 
their HRQoL during the last seven days based on 7-point Likert-type response categories 
ranging from “not bothered at all” to “extremely bothered,” with higher scores indicating 
better HRQoL.
Statistical Methods
Bivariate analyses were performed to test the association between HRQoL and asthma 
control status by individual time points (T1, T2, T3, T4), and the associations between the 
change in HRQoL and the changes in the levels of respective anchors (better, the same, and 
worse). For the association between HRQoL and asthma control status by individual time 
points, two-sample t-tests were conducted for comparing the mean HRQoL domain scores 
between those with poor and good asthma control status. To summarize the overall effect of 
asthma control status on HRQoL, generalized estimating equation (GEE) was used to 
examine the association of asthma control status with individual HRQoL domains across 
four time points by accounting for clustering effects of HRQoL within individuals [30].
The change in HRQoL associated with the changes in the levels of anchors was examined 
using paired t-tests. The association between the mean changes in HRQoL scores between 
children whose asthma control status became worse compared to those who remained the 
same/better was tested using two-sample t-tests. The analyses were conducted based on two 
categories (worse and the same/better) since the use of three change categories provided no 
additional information as opposed to two categories (i.e. the magnitude of change in HRQoL 
was similar for the same/better groups). Similarly, the two-category (worse vs. the same/
better) approach was performed for GRC breathing problems and overall health, 
respectively.
Relative validity was calculated to compare the efficiency and discriminative ability [31] 
between the individual domains of the PROMIS and the PAQLQ. Relative validity is 
calculated as a ratio of F-statistics across different domains, where the domain with the 
lowest F-statistic is used as the denominator and F-statistics of the other domains as the 
numerator. Domains with larger ratio values are considered superior to the other domains. 
SAS version 9.3 (SAS Institute, Inc., Cary, North Carolina, 2011) was used to conduct all 
analyses.
Results
Description of sample
Table 1 shows the characteristics of the study sample (N=229) at the baseline of the first 
year. The mean age for children was 12.2 years (SD: 2.6), and the sample was predominately 
male (59.9%), white (58.1%) and non-Hispanic (72.5%). Parents reported that 17% of the 
children in the sample had ADHD and 10.5% were overweight. The mean age for the 
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parents was 40.6 (SD: 8.7) and the majority of them were female (88.2%), white (58.1%), 
and non-Hispanic (74.2%). About 67% of the mother’s had some college education or 
above, and most families had a yearly income less than $35,000.
Association between asthma control and HRQoL by individual time points
Table 2 shows HRQoL domain scores by asthma control status at individual time points. 
Generally speaking, children with good control status reported better HRQoL than children 
with poor control status. Specifically, mean domain scores were statistically different 
between children with poor and good control status for the PROMIS asthma impact domain 
at T1, T2, T3 and T4, respectively. Means were are also statistically different between poor 
and good control status on the PROMIS pain interference domain at T3; the PROMIS 
fatigue domain at T1; and the PROMIS mobility domain at T1 and T2. For the PAQLQ, 
mean domain scores were statistically different between children with poor and good asthma 
control status on all domains at T1, T2, T3 and T4, respectively. GEE analyses indicate 
children with poor asthma control status reported significantly impaired HRQoL compared 
to children with good asthma control across four time points in the PROMIS asthma impact 
(β=4.31, p<0.001) and fatigue (β=1.96, p<0.01) domains, and all domains of the PAQLQ 
(Supplemental Table 1).
Association between HRQoL and asthma control status
Table 3 shows the association between the change in HRQoL and a specific change in 
asthma control status (worse and the same/better, respectively). Children whose asthma 
control status became worse reported a significant HRQoL deterioration on the PROMIS 
asthma impact domain (T1 to T2: p<0.01; T3 to T4: p<0.05), and the PAQLQ activity 
domain (T1 to T2: p<0.05). Unexpectedly, worsened asthma control status was associated 
with improved peer relationships on the PROMIS domain (T1 to T2: p<0.01). Those whose 
asthma remained the same/became better reported a significant HRQoL improvement on the 
PROMIS asthma impact domain (T1 to T2: p<0.001; T3 to T4; p<0.05), the PROMIS pain 
interference domain (T1 to T2: p<0.001), the PROMIS fatigue domain (T1 to T2: p<0.001; 
T3 to T4: p<0.05), the PROMIS mobility domain (T1 to T2: p<0.01), and all three domains 
of the PAQLQ (T1 to T2: p’s<0.001; T3 to T4; p’s<0.01).
Table 3 further shows the difference in the change of HRQoL scores between those with 
worse and the same/better asthma control status. From T1 to T2, the mean domain score 
difference was statistically significant for the PROMIS asthma impact (p<0.001), pain 
interference (p<0.05), fatigue (p<0.001), mobility (p<0.01), and peer relationships domains 
(p<0.05). The comparisons were also statistically significant on all three domains of the 
PAQLQ: symptom (p<0.001), activity (p<0.001) and emotional (p<0.01) domains. From T3 
to T4, the mean domain score change was statistically significant on the PROMIS asthma 
impact domain (p<0.01), and the PAQLQ symptom (p<0.001), activity (p<0.05) and 
emotional (p<0.01) domains.
Association between HRQoL and GRC Breathing Problems
Table 4 shows the association between the change in HRQoL and a specific change in 
breathing problems by GRC (worse and the same/better, respectively). Children whose 
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breathing problems became worse reported a significant HRQoL deterioration on the 
PROMIS asthma impact domain (T1 to T2: p<0.05; T3 to T4: p<0.01), the PROMIS 
mobility domain (T1 to T2: p<0.05) and the PAQLQ symptom domain (T1 to T2 and T3 to 
T4: p’s<0.05). Those whose breathing problems remained the same or became better 
reported significant HRQoL improvement on the PROMIS asthma impact (T1 to T2: 
p<0.01), pain interference (T1 to T2: p<0.001), fatigue (T1 to T2: p<0.01; T3 to T4: 
p<0.05), depressive symptoms (T3 to T4: p<0.001), mobility (T1 to T2: p<0.01), and peer 
relationships (T1 to T2: p<0.01) domains, and all PAQLQ domains (T1 to T2: p<0.001; T3 
to T4: p<0.001 for symptom and activity domains and p<0.01 for emotional domain).
Table 4 also shows the difference in the change of HRQoL scores between those with worse 
and the same/better breathing problems as reported on the GRC. From T1 to T2, 
comparisons were statistically significant on the PROMIS asthma impact (p<0.01), pain 
interference (p<0.05), fatigue (p<0.01), and mobility (p<0.01) domains. Comparisons were 
also statistically significant in all three PAQLQ domains: symptom (p<0.001), activity 
(p<0.001) and emotional (p <0.01). From T3 to T4, the comparisons were statistically 
significant on the PROMIS asthma impact (p<0.001) and depressive symptoms domains 
(p<0.05), and all three PAQLQ domains (p’s<0.001).
Association between HRQoL and GRC Overall Health
Table 5 shows the association between the change in HRQoL and a specific change in 
overall health reported on the GRC (worse and the same/better, respectively). Children 
whose overall health became worse reported a significant HRQoL deterioration on the 
PROMIS fatigue (T1 to T2: p<0.01), and peer relationships (T1 to T2: p<0.01) domains. 
Those whose overall health remained the same or became better reported a significant 
HRQoL improvement on all PROMIS and PAQLQ domains from T1 to T2, on the PROMIS 
fatigue and depressive symptoms (T3 to T4: p’s<0.05) domains, and on all three domains of 
the PAQLQ (T3 to T4: p’s<0.01).
Table 5 also shows the difference in the change of HRQoL scores between those with worse 
and the same/better overall health reported on the GRC. From T1 to T2, comparisons were 
statistically significant in the PROMIS pain interference (p<0.01), fatigue (p<0.001), 
depressive symptoms (p<0.05) and peer relationships (p<0.001) domains, and the PAQLQ 
symptom (p<0.05), activity (p<0.01), and emotional (p<0.01) domains. From T3 to T4, the 
comparisons were statistically significant on the PROMIS asthma impact domain (p<0.05) 
and all three PAQLQ (p’s<0.001) domains.
Relative Validity
Relative validity among individual domains of the PROMIS and PAQLQ related to 
individual anchors is reported in Tables 3–5. Using asthma control status as an anchor, the 
PROMIS asthma impact domain exhibited the highest relative validity (RV: 244.14) 
compared with other domains from T1 to T2. In contrast, the PAQLQ symptoms domain 
exhibited the highest relative validity from T3 to T4 (RV: 1860). Using GRC breathing 
problems as an anchor, the PAQLQ symptoms domain had highest relative validity both 
from T1 to T2 (RV: 1493) and from T3 to T4 (RV: 50.12). Using GRC overall health as an 
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anchor, the PROMIS fatigue domain exhibited the highest relative validity from T1 to T2 
(RV: 19.36), and the PAQLQ symptoms domain had the highest relative validity from T3 to 
T4 (RV: 109.20).
Discussion
The PROMIS Pediatric Asthma Study was designed to observe the natural course of 
pediatric asthma over 26 weeks within a two-year study period. Using a pediatric asthma 
cohort, we discovered the responsiveness as part of longitudinal validity for the PROMIS 
pediatric asthma impact and generic scales. The complex design feature similar to the 
PROMIS Pediatric Asthma Study has not been fully established in other HRQoL studies 
especially in pediatric asthma populations.
This study specifically found that children with worsened asthma control status, breathing 
problems, and overall health tended to report deteriorating HRQoL on both the PROMIS and 
PAQLQ scales; children with stable or improved asthma control status, breathing problems, 
and overall health reported improvements in HRQoL. The PROMIS asthma impact and 
several generic domains (such as pain interference, fatigue, and mobility) could significantly 
distinguish between the worse and the same/better asthma control, breathing problem and 
overall health groups, particularly between T1 and T2. Further, the PROMIS asthma impact 
domain was able to consistently discriminate between the worse and same/better change 
groups across all three anchors between T3 and T4.
Literature is sparse in assessing responsiveness to change for pediatric asthma HRQoL 
scales [32]. Our results are similar to that of Seid et al [33] who demonstrated 
responsiveness of the PedsQL generic and asthma impact scales reported by 252 asthmatic 
children between baseline and at 3-months. Using asthma symptom frequency as an anchor, 
the authors found that the PedsQL exhibited significant differences between those whose 
symptom frequency improved compared with those who remained stable in overall, 
psychosocial, social, and asthma domains. However, this study collected HRQoL at only two 
time points 3 months apart from each participant, and did not report the time/season of year 
that data were collected. Indeed, asthma is a season-dependent condition and few studies 
have carefully selected an appropriate observational window to test the responsiveness. Raat 
et al. demonstrated responsiveness for the PAQLQ in 238 Dutch children but only for 
children whose asthma symptoms became worse [19]. In contrast, our PROMIS Pediatric 
Asthma Study was designed to assess the dynamic change in asthma control status and 
corresponding change in HRQoL from each participant in two asthma-dependent seasons 
(e.g., Fall and Spring) across 4 time points among children whose asthma status became 
worse and improved, thus denoting a robust study design.
Although the PROMIS and PAQLQ domains did respond to change, the magnitude of 
change was more significant from T1 to T2 than from T3 to T4 (Tables 3–5). This could be 
attributed to children’s cognitive growth for interpreting the meaning of items over time, or 
could possibly be due to the provision of the asthma educational component between T2 and 
T3 to improve asthma management skills. Conducting cognitive appraisal would likely 
provide more insight regarding this finding. We also observed a more significant amount of 
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change in the majority of domains from participants in the same/better groups than those in 
the worse group particularly from T1 to T2. This finding is similar to Kheir et al [34] where 
asthmatic adults whose asthma improved over a 3-month period reported more significant 
amounts of change in HRQoL on the Asthma Quality of Life Questionnaire (AQLQ) than 
those who reported a worsening of asthma symptoms. Juniper et al [35] found mixed 
magnitudes of change on the GRC in asthmatic adults that either deteriorated or improved 
across 8-weeks. Since these two studies focused on adults, it is hard to draw inferences for 
the pediatric asthma population. Nevertheless, the findings derived from this and previous 
studies imply that the asymmetrical responsiveness in PROs related to the same/better and 
worse health status may influence the estimation of the clinically importance meaning [36].
Interestingly, the PROMIS asthma domain showed an equal but not superior responsiveness 
to the PAQLQ domains. The 8 items in the PROMIS asthma impact Short Form were 
selected from an IRT-calibrated item bank (17 items). Scales comprising a smaller number 
of items may not capture broader levels of the HRQoL latent traits than the individual 
domains of PAQLQ that comprises more items with more complete information. Yeatts et al 
[10] revealed that administering all 17-items in the PROMIS asthma impact item pool 
produced more precision than the Short Forms, implying that using all items for comparison 
may yield superior responsiveness to the PAQLQ. Given the comparable responsiveness 
between the PROMIS asthma impact Short Form and the PAQLQ asthma scales, the 
selection of scales for use depends upon the research or clinical purpose. If the purpose is to 
screen patients’ overall asthma impact, the use of the PROMIS asthma impact Short Form 
would be acceptable. However, if the purpose is to identify patients’ specific impact of 
asthma (e.g., physical or emotional domains), the use of PAQLQ may be appropriate. It is 
also important to note that several PROMIS generic domains (i.e. fatigue) possess 
satisfactory responsiveness that may be used alongside the asthma-specific scales.
Several limitations deserve notation. First, our study focuses on a Medicaid and SCHIP 
population who have exhibited a higher prevalence of children with asthma related to lower 
social economic status [37]; generalizability of our findings to other populations should be 
further investigated. Second, our sample is restricted to children and parents who were 
English-speaking only and different results may be observed in other non-English-speaking 
populations. Third, we used asthma control status and GRCs as anchors to evaluate 
responsiveness. Future studies may include biological or objective clinical anchors (e.g., 
lung functioning by FEV1 or peak flow values) to test responsiveness for HRQoL scales. In 
addition, asthma control status was reported via parent-proxy rather than by the child. 
Although using a parent-proxy may not be ideal [38], the ACCI probes information of 
asthma medications and flares of which parents may be more aware, particularly for younger 
children. Although previous studies have indicated that there were no significant differences 
between parents and adolescents in reporting of asthma medication use [39, 40], 
discrepancies between parent and younger children reports for asthma control status have 
not been examined.
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Conclusion
In sum, the asthma impact, pain interference, fatigue, and mobility domains of the PROMIS 
pediatric scales are responsive to change related to the change in health status in asthmatic 
children. The responsiveness of the PROMIS pediatric asthma impact domains was 
specifically comparable to the PAQLQ. This serves an important foundation for estimating 
MIDs in the PROMIS and PAQLQ scales, which can facilitate the use of HRQoL 
information in clinical decision-making.
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Figure 1. 
The design of PROMIS Pediatric Asthma Study
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Table 1
Patient Characteristics (N=229)
Child
Age, mean (SD) 12.2 (2.6)
  8–11 (N=102) 9.9 (0.8)
  12–14 (N=72) 12.8 (0.8)
  15–17.9 (N=55) 15.9 (1.0)
Female, % 41.1%
Race, %*
  White 58.1%
  Black 33.6%
  Other 17.0%
Ethnicity, %
  Hispanic 27.5%
  Non-Hispanic 72.5%
Chronic Conditions, %
  ADHD 17.0%
  Overweight 10.5%
  Mental Health Disorder 3.1%
  Epilepsy 2.6%
Seasonal cohort
  Fall (N=135) 59%
  Spring (N=94) 41%
Parent
Age, mean (SD) 40.6 (8.7)
Female, % 88.2%
Race, %*
  White 58.1%
  Black 29.3%
  Other 15.7%
Ethnicity, %
  Hispanic 25.8%
  Non-Hispanic 74.2%
Mother’s Education, %
  High school or below 32.7%
  Some college 42.5%
  College and above 24.8%
Family Income, %
  Less than $15,000 20.5%
  $15,000 to $34,999 44.5%
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  $35,000 to $54,999 24.9%
  More than $55,000 10.1%
Marital Relationship, %
  Married 51.5%
  Divorced 19.7%
  Never married 17.5%
  Other 11.3%
*
Race over 100% due to multiple choices
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